-
Cell: Scientists develop new blood tests that could improve screening for liver cancer
Time of Update: 2020-06-26
, June 15, 2020 /PRNewswire/ -- In a recent study published in the international journal Cell , scientists from the National Cancer Institute of the United States have developed a new test that ca
-
Science: COVID19 neutral antibodies show therapeutic potential
Time of Update: 2020-06-26
, June 16, 2020 /--- PRNewswire/ -- In a recent study, researchers at the Scripps Institute tested animal and human cells and found that antibodies in the blood of recovered COVID-19 patients provide
-
Cell: Building a widerange and useful model for COVID-19 morbidity, vaccination and treatment
Time of Update: 2020-06-26
, June 20, 2020 / Biovalley BIOON // New Coronary Pneumonia caused by SARS-CoV-2 is a highly toxic form of pneumonia, with nearly 8 million confirmed cases and 430,000 deaths worldwide as of June 15,
-
Cell: Mouse SARS-CoV-2 Infection Model Reveals Protective Effects of Neutralizing Antibodies
Time of Update: 2020-06-26
, June 2020 / Biovalley BIOON /- Severe Acute Respiratory Syndrome 2 coronavirus (SARS-CoV-2) has caused a pandemic in millions of people One limitation in evaluating potential therapies and vaccine
-
The FASEB J: Scientists discover a new mechanism that induces cellular immune response
Time of Update: 2020-06-26
, June 16, 2020 / Biovalley BIOON/ -- Viruses and other pathogenic microorganisms affect the type of immune response produced by the host body, in some cases, the main responses include antibody res
-
Nature: Reveals new molecular mechanisms in the extracellular trapping network of neutrophils that promote cancer metastasis through special protein molecules
Time of Update: 2020-06-26
, June 15, 2020 /PRNewswire- /UPI/ -- Scientists from China's Sun Yat-sen University and other institutions have revealed how the neutrophilcell extracyl traps cancer metastasis via CCDC25 has been
-
Nat Med: A single cell map that reveals peripheral immune response in patients with severe COVID-19!
Time of Update: 2020-06-26
Nat Med (2020) https://doi.org/10.1038/s41591-020-0944-y
-
New Crown Outbreak: 8.12 million worldwide! Lilly Launches COVID-19 Phase III Trial: JAK1/2 Inhibitor Olumiant Treats Cytokine Storm!
Time of Update: 2020-06-26
, June 16, 2020 / BIOON/ -- At present, the outbreak of new crown pneumonia abroad is still spreading rapidly According to Baidu's "Real-time Big Data Report on The New Coronavirus Pneumonia Outb
-
Natno Biotechl: Heavyweight! Scientists have developed an online map of human immunohiscism for precision medicine research!
Time of Update: 2020-06-26
, June 15, 2020 / PRNewswire/ -- In a recent study published in the international journal nature biotechnology , scientists from the Duke-NUS School of Medicine and others developed an interactive
-
Cell Stem Cell: Inducing pluripotent stem cells reprogramming into powerful natural killer cells enhances anti-tumor potential and activity
Time of Update: 2020-06-26
, June 15, 2020 /BIOON / --In a recent study published in the international journal Cell Stem Cell , scientists from the University of California and other institutions developed a key gene in the b
-
LSA: New biosensor technology may accelerate blood testing in PATIENTs with COVID-19
Time of Update: 2020-06-26
, June 15, 2020 / PRNewswire/ -- In a recent study published in the international journal Light: Science and app lications , scientists from the University of York and others have developed a new
-
Nat Metabol: New algorithms could use artificial intelligence to help manage people with type 1 diabetes
Time of Update: 2020-06-26
, June 16, 2020 /PRNewswire / -- In a recent study published in the international journal Nature Metabolism , scientists from institutions such as Oregon Health and Science University have develope
-
Nature is a major development! Redsiwe is effective for rhesus monkeys infected with SARS-CoV-2!
Time of Update: 2020-06-26
, June 16, 2020 /PRNewswire/ -- COVID-19 continues to sweep the world and is in urgent need of effective treatment for COVID-19 Although many drugs have been studied, approved and reused, preclinic
-
Nat Commun: Monitoring RNA hot spots or susceptible targets that can reveal cancer cells is expected to help develop new targeted anti-cancer therapies
Time of Update: 2020-06-26
, June 16, 2020 /PRNewswire / -- In a recent study published in the international journal nature communications , scientists from the University of California and other institutions have revealed a
-
Science: Neutrophils prefer to devour rod-like particles, or help treat cytokine storms in patients with COVID-19
Time of Update: 2020-06-26
, June 16, 2020 /PRNewswire/ -- bio-valley BIOON/--- immune system over-reaction is the most common cause of death in patients with COVID-19 A long-neglected group of white blood cells may play a c
-
Nat Commun: Cell pressure may promote cancer cells' resistance to chemotherapy to therapy
Time of Update: 2020-06-26
, June 15, 2020 / Biovalley BIOON/ -- There are many mechanisms associated with chemotherapy resistance, many of which are not currently known to researchers, and in a recent study published in the i
-
Front Microbiol: Eat more Chinese kimchi or prevent tooth decay!
Time of Update: 2020-06-26
, June 15, 2020 / BIOON/ -- In a recent study published in the international journal frontiers in Microbiology , scientists from the University of Bangorion and Chengdu University found that probio
-
Cell heavyweight! Chinese scientist David R. Liu develops a new way to predict gene editing results!
Time of Update: 2020-06-26
June 2020 / Biovalley BIOON / -- Although base editors are widely used to achieve fixed-point mutations, the factors that determine the results of base editing have not been well understood and of
-
New psoriasis drug! Uber's IL-17A/17F double inhibitor bimekizumab Phase III Project Success: Efficacy Beats Johnson and Johnson Stelara (Sidano)
Time of Update: 2020-06-26
, June 15, 2020 / Biovalley BIOON/UCB recently announced for the first time data on the clinical development program of the new anti-inflammatory drug bimekizumab for the treatment of moderate to se
-
Sci Immun: Scientists find T-cell subgroups that reduce risk of respiratory allergies and asthma
Time of Update: 2020-06-25
Introduction: It is well known that genetics and the environment are the two main causes of allergies and asthma But how allergies and asthma begin and develop remains a mystery In a recent article
